Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.79 USD | -7.39% | -11.01% | +1.30% |
Chart calendar Day One Biopharmaceuticals, Inc.
Upcoming events on Day One Biopharmaceuticals, Inc.
Past events on Day One Biopharmaceuticals, Inc.
2024-05-06 04:30 pm | Q1 2024 Earnings Release |
2024-04-24 08:30 am | OJEMDA™ FDA Approval Call |
2024-03-05 09:50 am | TD Cowen Health Care Conference |
2024-02-26 04:30 pm | Q4 2023 Earnings Release |
2024-01-08 01:30 pm | JPMorgan Healthcare Conference |
2023-11-28 11:30 am | Piper Sandler Healthcare Conference |
2023-11-17 01:25 pm | Society for Neuro Oncology Meeting - Abstract Number : CTNI-37 |
2023-11-17 01:15 pm | Society for Neuro Oncology Meeting - Abstract Number : CTNI-24 |
2023-11-06 04:30 pm | Q3 2023 Earnings Release |
2023-09-10 | Morgan Stanley Global Healthcare Conference |
2023-08-07 | Wedbush PacGrow Healthcare Conference |
2023-08-07 04:30 pm | Q2 2023 Earnings Release |
2023-06-22 | Society for Neuro-Oncology Biennial Pediatric Neuro-Oncology Research Conference |
2023-06-22 12:00 pm | Annual General Meeting |
2023-06-14 02:20 pm | Goldman Sachs Global Healthcare Conference |
2023-06-05 02:15 pm | American Society of Clinical Oncology Conference - Abstract Number: 10038 |
2023-06-05 02:15 pm | American Society of Clinical Oncology Conference - Abstract Number: TPS10067 |
2023-06-04 07:00 pm | American Society of Clinical Oncology Conference |
2023-06-04 10:45 am | American Society of Clinical Oncology Conference - Abstract Number: 10004 |
2023-05-09 | American Society of Pediatric Oncology/Hematology Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 14,9 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -72,5 -71,0 -2.23% | -147 -147 -0.15% | -206 -201 -2.25% | -271 |
EBIT Million USD | Released Forecast Spread | 0,00 | -72,7 -72,3 -0.55% | -147 -146 -0.83% | -206 -201 -2.66% | -260 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -72,8 -70,8 -2.73% | -142 -141 -0.58% | -189 -182 -4.08% | -245 |
Net income Million USD | Released Forecast Spread | -40,5 | -171 -136 -25.68% | -142 -143 0.54% | -189 -186 -1.58% | -247 |
EPS USD | Released Forecast Spread | -17,0 | -4,62 -3,77 -22.62% | -2,17 -2,18 0.52% | -2,37 -2,31 -2.45% | -2,81 |
Announcement Date | 04/05/21 | 07/03/22 | 06/03/23 | 26/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,91 | 4,46 | 9,79 | 19,7 | 26,6 |
EBITDA Million USD | Released Forecast Spread | -27,7 -24,0 -15.59% | -36,7 -30,0 -22.38% | -39,7 -41,0 3.26% | -42,7 -41,4 -3.22% | -51,4 -50,0 -2.85% | |||||||||
EBIT Million USD | Released Forecast Spread | -27,7 -25,3 -9.53% | -36,7 -30,0 -22.4% | -39,7 -37,5 -5.81% | -42,7 -41,6 -2.87% | -45,9 -45,3 -1.22% | -49,3 -47,7 -3.16% | -51,4 -50,6 -1.73% | -59,5 -54,2 -9.84% | -66,8 -60,2 -10.83% | -68,1 | -63,0 | -59,6 | -49,6 | -44,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,7 -25,9 -7.13% | -36,5 -29,9 -22.04% | -37,8 -37,1 -1.77% | -40,1 -39,6 -1.23% | -42,4 -41,6 -1.82% | -45,9 -44,0 -4.25% | -46,2 -47,4 2.74% | -54,5 -49,0 -11.25% | -62,4 -57,3 -8.93% | -64,9 | -61,0 | -57,3 | -47,9 | -42,6 |
Net income Million USD | Released Forecast Spread | -27,7 -25,9 -7.13% | -36,5 -29,9 -22.04% | -37,8 -37,4 -1.09% | -40,1 -40,6 1.3% | -42,4 -42,6 0.5% | -45,9 -45,3 -1.23% | -46,2 -48,3 4.46% | -54,5 -49,9 -9.18% | -62,4 -57,2 -9.02% | -64,1 | -60,9 | -57,2 | -47,9 | -42,6 |
EPS USD | Released Forecast Spread | -0,48 -0,40 -18.93% | -0,60 -0,49 -22.85% | -0,53 -0,53 0.61% | -0,56 -0,57 1.32% | -0,59 -0,59 -0.49% | -0,61 -0,61 -0.76% | -0,54 -0,60 10.31% | -0,64 -0,58 -10.54% | -0,72 -0,66 -8.68% | -0,74 | -0,70 | -0,64 | -0,53 | -0,47 |
Announcement Date | 12/05/22 | 04/08/22 | 07/11/22 | 06/03/23 | 01/05/23 | 07/08/23 | 06/11/23 | 26/02/24 | 06/05/24 | - | - | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Day One Biopharmaceuticals, Inc.
Today | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
Today | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DAWN Stock
- Calendar Day One Biopharmaceuticals, Inc.